VIE/DHRC (VIE/DHRC)

Vienna Stock Exchange: VIE/DHRC · EUR

€213

+2.20 (+1.0%)· Recorded snapshot

Market cap	149.3B
Revenue (ttm)	22.5B
Net income (ttm)	3.8B
EPS (ttm)	€5.47
P/E (trailing)	38.8x
P/E (forward)	25.6x
Dividend	€1.32 (0.62%)
Volume	51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 22.5B
Net income (ttm): 3.8B
EPS (ttm): €5.47
P/E (trailing): 38.8x
P/E (forward): 25.6x
Market cap: 149.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E25.6

P25 n/aP50 n/aP75 n/a

Trailing P/E38.8

P25 n/aP50 n/aP75 n/a

ROE8.2

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/DHRC indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-21
Employees	60,000
Employees change	-3,000
Employees growth	-4.76%
Enterprise value	EUR 169.1B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-25
First seen	2026-05-10
Fiscal year end	December
Founded	1969
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US2358511028
Last earnings date	2026-10-21
Last refreshed	2026-10-29
Market cap	EUR 149.3B
Price	EUR 212.50
Price currency	EUR
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-29
Symbol	vie/DHRC
Website	https://www.danaher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	34.56x
Average P/E ratio (3Y)	40.42x
Average P/E ratio (5Y)	36.35x
Earnings yield	2.58%
EV/Earnings	44.1x
EV/EBIT	33.2x
EV/EBITDA	21.76x
EV/FCF	33.35x
EV/Sales	7.29x
FCF / EV yield	3%
FCF yield	3.4%
Forward P/E	25.62x
Graham number	90.29624
Graham upside	-57.06%
Lynch fair value	EUR 27.05
Lynch upside	-87.14%
P/(FCF - SBC) ratio	31.19x
P/(OCF - SBC) ratio	25.78x
P/B ratio	3.14x
P/E ratio	38.81x
P/FCF ratio	29.4x
P/OCF ratio	24.55x
P/S ratio	6.57x
Price/EBITDA ratio	20.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.97%
EBITDA margin	32.24%
Effective tax rate	10.98%
FCF margin	21.88%
Gross margin	59.36%
Operating margin	21.97%
Pretax margin	18.81%
Profit margin	16.91%
Profit per employee	EUR 64,414
Profitable quarters	98
Profitable years	33
Revenue per employee	EUR 380,865
ROA	4.06%
ROA (5Y)	4.66%
ROCE	6.68%
ROE	8.19%
ROE (5Y)	9.78%
ROIC	6.6%
ROIC (5Y)	8.05%
SBC / revenue	1.28%
Tax / revenue	2.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	25.42%
EPS growth (Q)	37.77%
EPS growth (QoQ)	42.25%
EPS growth 10Y	5.5%
EPS growth 3Y	-8.35%
EPS growth 5Y	-4.99%
EPS growth quarters	5
EPS growth years	0
FCF growth	14.15%
FCF growth 3Y	-5.76%
FCF growth 5Y	-4.09%
Gross profit growth	5.11%
Gross profit growth (Q)	12.77%
Gross profit growth 3Y	6.93%
Gross profit growth 5Y	-2.4%
Net income growth	23.64%
Net income growth (Q)	36.01%
Net income growth (QoQ)	41.95%
Net income growth 3Y	-9.66%
Net income growth 5Y	-5.42%
Net income growth quarters	5
Net income growth years	0
OCF growth	8.56%
OCF growth 10Y	5.27%
OCF growth 3Y	-5.34%
OCF growth 5Y	-3.62%
Operating income growth	7.1%
Operating income growth (Q)	10.27%
Operating income growth 3Y	3.87%
Operating income growth 5Y	-6.08%
Revenue growth	5.52%
Revenue growth (Q)	8.28%
Revenue growth (QoQ)	4.61%
Revenue growth 10Y	4.42%
Revenue growth 3Y	6.79%
Revenue growth 5Y	-1.82%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -993.3M
Depreciation and amortization	EUR 2.4B
EBIT	EUR 4.9B
EBITDA	EUR 7.2B
EPS	EUR 5.47
Financing cash flow	EUR 7.4B
Free cash flow	EUR 5B
Free cash flow minus SBC	EUR 4.7B
Gross profit	EUR 13.3B
Income taxes	EUR 464.2M
Investing cash flow	EUR -9.7B
Net borrowing	EUR 9.2B
Net cash flow	EUR 3.6B
Net income	EUR 3.8B
Operating cash flow minus SBC	EUR 5.7B
Operating income	EUR 4.9B
Revenue	EUR 22.5B
Stock-based compensation	EUR 288.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.47
Book value per share	EUR 66.89
Debt / EBITDA	3.24
Debt / equity	0.52
Debt / FCF	4.85
Goodwill	EUR 42.4B
Interest coverage	15.63
Long-term assets	EUR 68.6B
Long-term liabilities	EUR 26.7B
Net cash (debt)	EUR -19.4B
Net cash / market cap	-13.13%
Net debt / EBITDA	2.68
Net debt / equity	0.41
Net debt / FCF	3.86
Piotroski F-Score	5
Property, plant and equipment	EUR 6.3B
Shareholders' equity	EUR 47.1B
Tangible book value	EUR -12.9B
Tangible book value per share	EUR -18.40
Total assets	EUR 81.9B
Total cash	EUR 5B
Total debt	EUR 24.4B
Total liabilities	EUR 34.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.3
Current assets	EUR 13.3B
Current liabilities	EUR 8.1B
Current ratio	1.63
Inventory turnover	3.58
Net working capital	EUR 1.9B
Quick ratio	1.19
Working capital	EUR 5B
Working capital turnover	4.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.6%
Dividend growth	19.89%
Dividend growth (3Y)	10.27%
Dividend growth (5Y)	14.21%
Dividend growth years	7
Dividend payment date	2026-10-30
Dividend payment years	9
Dividend payout frequency	Quarterly
Dividend per share	EUR 1.32
Dividend yield	0.62%
Ex-dividend date	2026-09-30
Last dividend	EUR 0.35
Payout ratio	23.46%
Shareholder yield	2.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 171.08
1D price change	1.05%
1M price change	7.05%
1M total return	7.24%
1W price change	9.82%
1W total return	9.82%
1Y price change	13.27%
1Y return CAGR	14.13%
1Y total return	14.12%
20-day SMA	EUR 199.87
200-day SMA	EUR 173.60
3M price change	20.98%
3M total return	21.2%
3Y price change	17.83%
3Y return CAGR	6.24%
3Y total return	19.93%
50-day SMA	EUR 190.19
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 213.40
52-week high date	2026-10-29
52-week low	EUR 138.30
52-week low date	2026-05-18
5Y price change	-18.77%
5Y return CAGR	-1.24%
5Y total return	-6.04%
6M price change	39.9%
6M total return	40.44%
All-time high	EUR 297.50
All-time high date	2022-08-16
All-time low	EUR 115.88
All-time low date	2020-03-20
Average true range (ATR)	EUR 4.82
Average volume	49.8
Change from 52-week high	0%
Change from 52-week low	53.65%
Change from all-time high	-28.57%
Change from all-time low	83.38%
Change from open	-0.14%
Day's gap	1.19%
Dollar volume	EUR 10,838
High price	EUR 213.40
Low price	EUR 210.80
Monthly RSI	58.45
Open price	EUR 212.80
Position in 52-week range	65.38%
Previous close	EUR 210.30
Price vs 150-day SMA	24.21%
Price vs 20-day SMA	6.32%
Price vs 200-day SMA	22.41%
Price vs 50-day SMA	11.73%
Relative volume	1.08
RSI	65.09
Sharpe ratio	0.4
Sharpe ratio (3Y)	0.12
Sharpe ratio (5Y)	-0.05
Sortino ratio	0.69
Sortino ratio (3Y)	0.36
Sortino ratio (5Y)	0.13
Volume	51
Weekly RSI	68.27
YTD price change	8.5%
YTD total return	9.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	626.3M
Shares change (QoQ)	-0.11%
Shares change (YoY)	-1.6%
Shares held by insiders	10.86%
Shares held by institutions	83.37%
Short ratio	2 days

Deeper analysis on VIE/DHRC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/DHRC report

Is a complete VIE/DHRC research report available?

No complete published report is available for vie/DHRC (VIE/DHRC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/DHRC (VIE/DHRC)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/DHRC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/DHRC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/DHRC

Frequently asked questions